Revenue decline due to a slowdown in activities following the M&A of an OEM supply partner
First written in FY2023-Q2. 1 of 3 entries say "Materialised", first in FY2023-Q3. Latest entry: FY2024-Q2.
No other company in this theme has enough history to compare yet.
- FY2024-Q2MitigatedAnnual report
「Revenue from pharmacy-support equipment and other products increased year on year, as campaigns to switch from older models and other initiatives in the U.S. market proved effective.」
Unlike the previous period, when a slowdown in activity following an M&A transaction involving a U.S. OEM customer was reported, related revenue increased year on year due to campaigns to switch from older models and other initiatives. - FY2023-Q3MaterialisedAnnual report
「Revenue from pharmacy-support equipment and other products declined in the Americas due to a slowdown in activity during the second quarter following an M&A transaction involving an OEM customer, but performed strongly in Japan as the market recovered, resulting in higher revenue overall.」
The second-quarter slowdown in activity in the Americas following an M&A transaction involving an OEM customer was reflected in lower revenue from pharmacy-support equipment and other products. - FY2023-Q2First statedAnnual report
「Revenue from pharmacy-support equipment and other products declined in the Americas due to a temporary slowdown in activity following an M&A transaction involving an OEM customer, but performed strongly in Japan as the market recovered, resulting in higher revenue overall.」
A temporary slowdown in activity in the Americas following an M&A transaction involving an OEM customer was a factor behind lower revenue from pharmacy-support equipment and other products.